SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Andrew H who wrote (337)6/12/1998 12:00:00 PM
From: macker  Read Replies (1) of 5402
 
exactly pre-fda, but not fda phase 1, big difference. they will not even be filing for fda approval for a while unless baxter pulls some strings for them. there are different phases within each phase as well, there is A and A prime, B and B prime which is considered phase 1 and 2 within each phase. this is confusing to many and is what also caused a lot of stockholder upset in january when holders had it explained to them, the confusion over pre-fda clinical phases and fda clinical phases obviously still exists, the 10 k confused many. also the phase 2 trials were not conclusive and they had to get more data and enroll more patients so phase 2 has not even been completed.

macker
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News